Peter Ordentlich - Net Worth and Insider Trading
Peter Ordentlich Net Worth
The estimated net worth of Peter Ordentlich is at least $0 dollars as of 2025-01-12. Peter Ordentlich is the Chief Scientific Officer of Syndax Pharmaceuticals Inc and owns about 0 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $0. Details can be seen in Peter Ordentlich's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Ordentlich has not made any transactions after 2023-02-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Ordentlich
Peter Ordentlich Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Ordentlich owns 1 companies in total, including Syndax Pharmaceuticals Inc (SNDX) .
Click here to see the complete history of Peter Ordentlich’s form 4 insider trades.
Insider Ownership Summary of Peter Ordentlich
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2023-02-15 | Chief Technology Officer |
Peter Ordentlich Latest Holdings Summary
Peter Ordentlich currently owns a total of 1 stock. Peter Ordentlich owns 0 shares of Syndax Pharmaceuticals Inc (SNDX) as of February 15, 2023, with a value of $0.
Latest Holdings of Peter Ordentlich
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2023-02-15 | 0 | 13.11 | 0 |
Holding Weightings of Peter Ordentlich
Peter Ordentlich Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Ordentlich has made a total of 6 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 25,000 shares on February 15, 2023, which brought Peter Ordentlich around $646,000.
Insider Trading History of Peter Ordentlich
- 1
Peter Ordentlich Trading Performance
Peter Ordentlich Ownership Network
Ownership Network List of Peter Ordentlich
Ownership Network Relation of Peter Ordentlich
Peter Ordentlich Owned Company Details
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
Peter Ordentlich is the Chief Technology Officer of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, Peter Ordentlich made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 83,000 shares made by William Meury , a net sale of 52,855 shares made by Briggs Morrison , and a net purchase of 1,250 shares made by Keith A. Goldan .
In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 135,855 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 134,605 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
Peter Ordentlich Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Ordentlich. You might contact Peter Ordentlich via mailing address: C/o Syndax Pharmaceuticals, Inc., 400 Totten Pond Road, Suite 140, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
